Concurrent Stereotactic Body Radiation Therapy and KRAS Inhibition Synergistically Improve Pre-clinical Pancreatic Cancer Treatment
Tianyu Wang, Linghua Wang, Jiaqian Xu, Youming Guo, Lu Xia, Yuting Li, Fada Guan, Boyi Gan, David S. Hong, Vincent Bernard, Dadi Jiang, Albert C. Koong
This study shows that combining stereotactic body radiation therapy with KRAS inhibition synergistically improves preclinical pancreatic cancer treatment by enhancing tumor control and reducing recurrence.
bioRxiv · Jul 13, 2026 · PreprintCancer Biology